Celsius (NASDAQ:CELH - Get Free Report) is anticipated to issue its Q1 2025 quarterly earnings data before the market opens on Tuesday, May 6th. Analysts expect the company to announce earnings of $0.19 per share and revenue of $349.09 million for the quarter.
Celsius (NASDAQ:CELH - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.11 by $0.03. The firm had revenue of $332.20 million for the quarter, compared to analysts' expectations of $326.07 million. Celsius had a net margin of 10.70% and a return on equity of 51.89%. On average, analysts expect Celsius to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Celsius Stock Down 0.3 %
Celsius stock traded down $0.09 during mid-day trading on Thursday, hitting $34.87. The company's stock had a trading volume of 4,238,813 shares, compared to its average volume of 7,823,540. The stock has a market capitalization of $8.99 billion, a P/E ratio of 79.25, a P/E/G ratio of 2.90 and a beta of 1.58. The stock's fifty day moving average price is $32.91 and its two-hundred day moving average price is $29.58. Celsius has a twelve month low of $21.10 and a twelve month high of $98.85.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on CELH. LADENBURG THALM/SH SH dropped their price target on Celsius from $62.00 to $58.00 and set a "neutral" rating on the stock in a research report on Thursday, March 27th. Roth Mkm reissued a "buy" rating and issued a $38.00 price target on shares of Celsius in a research report on Friday, February 21st. TD Cowen lowered shares of Celsius from a "buy" rating to a "hold" rating and dropped their price objective for the company from $40.00 to $29.00 in a research note on Wednesday, January 22nd. Truist Financial raised Celsius from a "hold" rating to a "buy" rating and lifted their price objective for the company from $35.00 to $45.00 in a research report on Monday, March 31st. Finally, Needham & Company LLC lifted their target price on shares of Celsius from $40.00 to $45.00 and gave the company a "buy" rating in a research note on Wednesday, April 9th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and twelve have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $46.47.
View Our Latest Stock Report on Celsius
Insider Buying and Selling
In related news, Director Joyce Russell sold 4,000 shares of the company's stock in a transaction dated Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total value of $113,880.00. Following the sale, the director now owns 19,106 shares of the company's stock, valued at $543,947.82. The trade was a 17.31 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Paul H. Storey sold 10,188 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $25.77, for a total value of $262,544.76. Following the completion of the sale, the insider now owns 45,297 shares in the company, valued at approximately $1,167,303.69. This represents a 18.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.
About Celsius
(
Get Free Report)
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Further Reading

Before you consider Celsius, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celsius wasn't on the list.
While Celsius currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.